Anderson Hoagland & Co’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q4 | – | Sell |
-70,426
| Closed | -$4.17M | – | 109 |
|
|
2021
Q3 | $4.17M | Buy |
70,426
+500
| +0.7% | +$29.6K | 0.53% | 50 |
|
|
2021
Q2 | $4.67M | Buy |
69,926
+4,006
| +6% | +$268K | 0.59% | 48 |
|
|
2021
Q1 | $4.16M | Buy |
65,920
+1,914
| +3% | +$121K | 0.59% | 50 |
|
|
2020
Q4 | $3.97M | Buy |
64,006
+26,326
| +70% | +$1.63M | 0.63% | 46 |
|
|
2020
Q3 | $2.22M | Sell |
37,680
-1,050
| -3% | -$61.8K | 1.06% | 25 |
|
|
2020
Q2 | $2.28M | Buy |
38,730
+335
| +0.9% | +$19.7K | 1.07% | 25 |
|
|
2020
Q1 | $1.9M | Buy |
38,395
+6,700
| +21% | +$331K | 1.17% | 24 |
|
|
2019
Q4 | $1.81M | Buy |
+31,695
| New | +$1.81M | 1.02% | 27 |
|